Programmed Death-Ligand 1 Tumor Proportion Score and Overall Survival from First-Line Pembrolizumab in Patients with Nonsquamous Versus Squamous NSCLC.
Journal of Thoracic Oncology（2021）
Key words
PD-L1,NSCLC,Histology,Biomarkers
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined